AASLD / AMH / CASL COVID-19 and the Liver in North America: Impact of Contrasting Health Care Systems

Date: Thursday, September 24, 2020
Presenters: Kelly W. Burak, MD, FRCPC, MSc(Epid) | Laura Cisneros, MD | Brett E, Fortune, MD, MSc

On September 24, AASLD / AMH / CASL joined forces to lead a timely discussion on the impact of the varied public health responses to the COVID-19 pandemic on patients with liver disease. After providing an update on the burden of COVID-19 in general and on the liver patient population throughout North America, speakers and panelists from Canada, Mexico and the United States discussed similarities and differences in terms of access to care in the three countries and address ways in which clinicians and researchers can address health care disparities in their own practices.

This webinar:

Reviews the burden of COVID-19 in general and within the hepatology patient population in Canada, Mexico, and the United States.

Compares and contrasts current public health measures, guidelines, and community response throughout North America.

Describes the similarities and differences in access to care and related to health care disparities by region.

Identifies possible solutions to reduce regional health care disparities related to COVID-19 in patients with liver disease.

Download the slide deck [PDF].